Trial Profile
A Phase II Trial of Docetaxel-polymeric Micelles(PM) Plus Oxaliplatin as a First-line Chemotherapy in Patients With Esophageal Squamous Cell Carcinoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2021
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Oxaliplatin (Primary)
- Indications Gastric cancer; Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms DOSE
- 17 Jul 2018 New trial record